Annual Working Capital
$242.32 M
-$117.69 M-32.69%
September 30, 2024
Summary
- As of February 8, 2025, ENTA annual working capital is $242.32 million, with the most recent change of -$117.69 million (-32.69%) on September 30, 2024.
- During the last 3 years, ENTA annual working capital has fallen by -$40.53 million (-14.33%).
- ENTA annual working capital is now -41.28% below its all-time high of $412.68 million, reached on September 30, 2020.
Performance
ENTA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$242.32 M
+$13.96 M+6.12%
September 30, 2024
Summary
- As of February 8, 2025, ENTA quarterly working capital is $242.32 million, with the most recent change of +$13.96 million (+6.12%) on September 30, 2024.
- Over the past year, ENTA quarterly working capital has dropped by -$117.69 million (-32.69%).
- ENTA quarterly working capital is now -43.75% below its all-time high of $430.76 million, reached on June 30, 2019.
Performance
ENTA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ENTA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.7% | -32.7% |
| 3 y3 years | -14.3% | -14.3% |
| 5 y5 years | -36.1% | -14.3% |
ENTA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.7% | at low | -36.3% | +6.1% |
| 5 y | 5-year | -41.3% | at low | -42.7% | +6.1% |
| alltime | all time | -41.3% | +955.9% | -43.8% | +955.9% |
Enanta Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $242.32 M(-32.7%) | $242.32 M(+6.1%) |
| Jun 2024 | - | $228.35 M(-23.0%) |
| Mar 2024 | - | $296.42 M(-9.6%) |
| Dec 2023 | - | $327.90 M(-8.9%) |
| Sep 2023 | $360.00 M(+27.7%) | $360.00 M(-5.3%) |
| Jun 2023 | - | $380.28 M(+59.1%) |
| Mar 2023 | - | $238.97 M(-8.3%) |
| Dec 2022 | - | $260.70 M(-7.5%) |
| Sep 2022 | $281.89 M(-0.3%) | $281.89 M(-2.8%) |
| Jun 2022 | - | $290.00 M(-6.8%) |
| Mar 2022 | - | $311.13 M(+7.6%) |
| Dec 2021 | - | $289.07 M(+2.2%) |
| Sep 2021 | $282.85 M(-31.5%) | $282.85 M(-3.3%) |
| Jun 2021 | - | $292.53 M(-27.2%) |
| Mar 2021 | - | $401.60 M(-5.0%) |
| Dec 2020 | - | $422.90 M(+2.5%) |
| Sep 2020 | $412.68 M(+8.8%) | $412.68 M(+6.0%) |
| Jun 2020 | - | $389.47 M(+1.6%) |
| Mar 2020 | - | $383.19 M(-9.1%) |
| Dec 2019 | - | $421.37 M(+11.1%) |
| Sep 2019 | $379.24 M(+4.1%) | $379.24 M(-12.0%) |
| Jun 2019 | - | $430.76 M(+6.8%) |
| Mar 2019 | - | $403.35 M(+0.7%) |
| Dec 2018 | - | $400.68 M(+10.0%) |
| Sep 2018 | $364.36 M | $364.36 M(+11.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $325.86 M(+12.9%) |
| Mar 2018 | - | $288.56 M(+26.3%) |
| Dec 2017 | - | $228.40 M(+5.3%) |
| Sep 2017 | $216.84 M(-3.3%) | $216.84 M(+11.2%) |
| Jun 2017 | - | $194.99 M(+7.5%) |
| Mar 2017 | - | $181.44 M(-16.6%) |
| Dec 2016 | - | $217.63 M(-3.0%) |
| Sep 2016 | $224.27 M(+36.8%) | $224.27 M(-3.4%) |
| Jun 2016 | - | $232.22 M(+0.7%) |
| Mar 2016 | - | $230.68 M(+16.4%) |
| Dec 2015 | - | $198.15 M(+20.9%) |
| Sep 2015 | $163.94 M(+58.8%) | $163.94 M(-0.8%) |
| Jun 2015 | - | $165.33 M(+4.6%) |
| Mar 2015 | - | $157.99 M(-4.4%) |
| Dec 2014 | - | $165.23 M(+60.1%) |
| Sep 2014 | $103.23 M(+3.0%) | $103.23 M(-3.9%) |
| Jun 2014 | - | $107.41 M(+13.1%) |
| Mar 2014 | - | $94.93 M(+3.4%) |
| Dec 2013 | - | $91.81 M(-8.4%) |
| Sep 2013 | $100.19 M(+141.0%) | $100.19 M(+5.5%) |
| Jun 2013 | - | $94.92 M(-11.0%) |
| Mar 2013 | - | $106.71 M(+86.6%) |
| Dec 2012 | - | $57.18 M(+37.5%) |
| Sep 2012 | $41.57 M(+81.2%) | $41.57 M(-11.3%) |
| Jun 2012 | - | $46.86 M(+104.2%) |
| Sep 2011 | $22.95 M | $22.95 M |
FAQ
- What is Enanta Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals annual working capital year-on-year change?
- What is Enanta Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals quarterly working capital year-on-year change?
What is Enanta Pharmaceuticals annual working capital?
The current annual working capital of ENTA is $242.32 M
What is the all time high annual working capital for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high annual working capital is $412.68 M
What is Enanta Pharmaceuticals annual working capital year-on-year change?
Over the past year, ENTA annual working capital has changed by -$117.69 M (-32.69%)
What is Enanta Pharmaceuticals quarterly working capital?
The current quarterly working capital of ENTA is $242.32 M
What is the all time high quarterly working capital for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high quarterly working capital is $430.76 M
What is Enanta Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, ENTA quarterly working capital has changed by -$117.69 M (-32.69%)